Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome.

Leventhal AM, Lee W, Bergen AW, Swan GE, Tyndale RF, Lerman C, Conti DV.

Drug Alcohol Depend. 2014 May 1;138:109-17. doi: 10.1016/j.drugalcdep.2014.02.016. Epub 2014 Mar 5.

2.

Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.

Ray R, Mitra N, Baldwin D, Guo M, Patterson F, Heitjan DF, Jepson C, Wileyto EP, Wei J, Payne T, Ma JZ, Li MD, Lerman C.

Neuropsychopharmacology. 2010 May;35(6):1374-82. doi: 10.1038/npp.2010.7. Epub 2010 Feb 10.

3.

Molecular genetics of successful smoking cessation: convergent genome-wide association study results.

Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE, David SP, Niaura R, Lerman C.

Arch Gen Psychiatry. 2008 Jun;65(6):683-93. doi: 10.1001/archpsyc.65.6.683.

4.

Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients.

De Ruyck K, Nackaerts K, Beels L, Werbrouck J, De Volder A, Meysman M, Salhi B, Van Meerbeeck J, Thierens H.

Pharmacogenomics. 2010 Aug;11(8):1053-63. doi: 10.2217/pgs.10.75.

PMID:
20712524
5.

Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation.

Spruell T, Colavita G, Donegan T, Egawhary M, Hurley M, Aveyard P, Johnstone EC, Murphy MF, Munafò MR.

Nicotine Tob Res. 2012 Aug;14(8):993-7. doi: 10.1093/ntr/ntr246. Epub 2011 Dec 17.

PMID:
22180580
6.

Alpha-5 and -3 nicotinic receptor gene variants predict nicotine dependence but not cessation: findings from the COMMIT cohort.

Bousman CA, Rivard C, Haese JD, Ambrosone C, Hyland A.

Am J Med Genet B Neuropsychiatr Genet. 2012 Mar;159B(2):227-35. doi: 10.1002/ajmg.b.32019. Epub 2012 Jan 5.

7.

Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation.

Conti DV, Lee W, Li D, Liu J, Van Den Berg D, Thomas PD, Bergen AW, Swan GE, Tyndale RF, Benowitz NL, Lerman C; Pharmacogenetics of Nicotine Addiction and Treatment Consortium.

Hum Mol Genet. 2008 Sep 15;17(18):2834-48. doi: 10.1093/hmg/ddn181. Epub 2008 Jul 1.

8.

Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success.

Chen LS, Baker TB, Piper ME, Breslau N, Cannon DS, Doheny KF, Gogarten SM, Johnson EO, Saccone NL, Wang JC, Weiss RB, Goate AM, Bierut LJ.

Am J Psychiatry. 2012 Jul;169(7):735-42. doi: 10.1176/appi.ajp.2012.11101545.

9.

Role of nicotine dependence on the relationship between variants in the nicotinic receptor genes and risk of lung adenocarcinoma.

Tseng TS, Park JY, Zabaleta J, Moody-Thomas S, Sothern MS, Chen T, Evans DE, Lin HY.

PLoS One. 2014 Sep 18;9(9):e107268. doi: 10.1371/journal.pone.0107268. eCollection 2014.

10.

Nicotinic acetylcholine receptor genes on chromosome 15q25.1 are associated with nicotine and opioid dependence severity.

Erlich PM, Hoffman SN, Rukstalis M, Han JJ, Chu X, Linda Kao WH, Gerhard GS, Stewart WF, Boscarino JA.

Hum Genet. 2010 Nov;128(5):491-9. doi: 10.1007/s00439-010-0876-6. Epub 2010 Aug 20.

PMID:
20725741
11.

Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes.

Saccone NL, Saccone SF, Hinrichs AL, Stitzel JA, Duan W, Pergadia ML, Agrawal A, Breslau N, Grucza RA, Hatsukami D, Johnson EO, Madden PA, Swan GE, Wang JC, Goate AM, Rice JP, Bierut LJ.

Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 5;150B(4):453-66. doi: 10.1002/ajmg.b.30828.

12.

Prospective association of dopamine-related polymorphisms with smoking cessation in general care.

Breitling LP, Twardella D, Hoffmann MM, Witt SH, Treutlein J, Brenner H.

Pharmacogenomics. 2010 Apr;11(4):527-36. doi: 10.2217/pgs.10.1.

PMID:
20350135
13.

DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers.

Lee W, Ray R, Bergen AW, Swan GE, Thomas P, Tyndale RF, Benowitz NL, Lerman C, Conti DV.

Pharmacogenet Genomics. 2012 Jul;22(7):551-4. doi: 10.1097/FPC.0b013e3283539062.

14.

CHRNA4 and tobacco dependence: from gene regulation to treatment outcome.

Hutchison KE, Allen DL, Filbey FM, Jepson C, Lerman C, Benowitz NL, Stitzel J, Bryan A, McGeary J, Haughey HM.

Arch Gen Psychiatry. 2007 Sep;64(9):1078-86.

PMID:
17768273
15.

Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor beta2-subunit (CHRNB2) gene show no association with smoking initiation or nicotine dependence.

Silverman MA, Neale MC, Sullivan PF, Harris-Kerr C, Wormley B, Sadek H, Ma Y, Kendler KS, Straub RE.

Am J Med Genet. 2000 Oct 9;96(5):646-53.

PMID:
11054772
16.

Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs.

Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE.

BMC Genet. 2007 Apr 3;8:10.

17.

Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.

Sarginson JE, Killen JD, Lazzeroni LC, Fortmann SP, Ryan HS, Ameli N, Schatzberg AF, Murphy GM Jr.

Nicotine Tob Res. 2015 Sep;17(9):1126-33. doi: 10.1093/ntr/ntu273. Epub 2015 Jan 8.

18.

Dopamine-related genes and spontaneous smoking cessation in ever-heavy smokers.

Breitling LP, Müller H, Illig T, Rujescu D, Winterer G, Dahmen N, Nitz B, Raum E, Rothenbacher D, Brenner H.

Pharmacogenomics. 2011 Aug;12(8):1099-106. doi: 10.2217/pgs.11.74. Epub 2011 Aug 1.

PMID:
21806388
19.

Associations of nicotine intake measures with CHRN genes in Finnish smokers.

Keskitalo-Vuokko K, Pitkäniemi J, Broms U, Heliövaara M, Aromaa A, Perola M, Ripatti S, Salminen O, Salomaa V, Loukola A, Kaprio J.

Nicotine Tob Res. 2011 Aug;13(8):686-90. doi: 10.1093/ntr/ntr059. Epub 2011 Apr 16.

20.

Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy.

Sarginson JE, Killen JD, Lazzeroni LC, Fortmann SP, Ryan HS, Schatzberg AF, Murphy GM Jr.

Am J Med Genet B Neuropsychiatr Genet. 2011 Apr;156B(3):275-84. doi: 10.1002/ajmg.b.31155. Epub 2011 Jan 25.

PMID:
21268243

Supplemental Content

Support Center